Thymosin Alpha-1

What it is

Thymosin Alpha-1 (Tα1) is a naturally occurring immune-modulating peptide originally isolated from thymus tissue.

It plays a central role in supporting immune resilience, cellular defence, and inflammatory balance.

Research has explored its potential to help the body respond more effectively to infections, chronic stress, and immune dysregulation.

Key benefits

  • Immune support: Promotes activation and balance of T-cells and natural killer (NK) cells.
  • Inflammation regulation: Helps modulate cytokine activity for a balanced immune response.
  • Cellular defence: Encourages the body’s own repair and surveillance systems.
  • Synergy with recovery peptides: Often paired with BPC-157 or TB-500 to support systemic recovery.
  • Stress resilience: Early findings suggest it may help normalise immune function during periods of physical or emotional stress.

How it works (in simple terms)

Tα1 communicates with immune cells through T-cell receptor pathways and cytokine signalling.

It doesn’t suppress the immune system — it helps restore balance, enhancing underactive defences while calming excessive inflammation.

Forms & typical use

  • Subcutaneous injection: The most common form studied.
  • Intranasal delivery: Occasionally used in experimental or clinical research for systemic immune support.

Typical research range: 1–2 mg, two or three times per week (from published research protocols).

 For research and educational reference only — Thymosin Alpha-1 is not a licensed therapeutic product.

Smart peptide combinations

Research summary

Responsible use